Table 2.

Examples of individual immunophenotypic features with reported prognostic significance in diffuse large B-cell lymphomas (DLBCL).

ImmunophenotypeImpact on Prognosis
bcl-2 expression adverse 
bcl-6 expression favorable 
HLA class II expression favorable 
Mutated p53 adverse 
High proliferative rate defined by Ki-67 adverse 
Tumor-infiltrating lymphocytes favorable 
CD5 expression adverse 
MUM-1 positive adverse 
Cyclin D2 positive adverse 
ImmunophenotypeImpact on Prognosis
bcl-2 expression adverse 
bcl-6 expression favorable 
HLA class II expression favorable 
Mutated p53 adverse 
High proliferative rate defined by Ki-67 adverse 
Tumor-infiltrating lymphocytes favorable 
CD5 expression adverse 
MUM-1 positive adverse 
Cyclin D2 positive adverse 
Close Modal

or Create an Account

Close Modal
Close Modal